IN BRIEF: Oncimmune shares lifted on two new US contract wins
Oncimmune Holdings PLC - Nottingham-based immunodiagnostics developer - Signs two further ImmunoInsights commercial contracts. One contract is with an unnamed US-based clinical-stage biopharmaceutical company, that...
Fri, 08/04/2022 - 10:54